Private Trust Co. NA Increases Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Private Trust Co. NA increased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 402.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 442 shares of the biotechnology company’s stock after buying an additional 354 shares during the period. Private Trust Co. NA’s holdings in Axon Enterprise were worth $263,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. New Wave Wealth Advisors LLC purchased a new position in Axon Enterprise during the fourth quarter worth approximately $40,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise during the 4th quarter worth $45,000. Prestige Wealth Management Group LLC raised its position in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the period. Stonebridge Financial Group LLC acquired a new position in Axon Enterprise in the fourth quarter valued at $53,000. Finally, GPS Wealth Strategies Group LLC grew its position in Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after acquiring an additional 40 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Axon Enterprise Stock Performance

Shares of AXON opened at $525.75 on Tuesday. The firm has a market cap of $40.09 billion, a price-to-earnings ratio of 135.85, a PEG ratio of 5.17 and a beta of 1.05. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business’s 50 day moving average is $607.58 and its two-hundred day moving average is $526.43. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price objective on the stock. in a report on Thursday, February 20th. Barclays set a $726.00 price target on shares of Axon Enterprise and gave the company an “overweight” rating in a research report on Thursday. Northland Securities boosted their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $587.38.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $639.69, for a total value of $639,690.00. Following the transaction, the director now directly owns 24,259 shares in the company, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,407 shares of company stock valued at $4,122,925 over the last ninety days. Corporate insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.